```

[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[S. 1094 Referred in House (RFH)]

  1st Session
                                S. 1094

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           November 19, 2001

            Referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 AN ACT

 
    To amend the Public Health Service Act to provide for research, 
        information, and education with respect to blood cancer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Hematological Cancer Research 
Investment and Education Act of 2001''.

SEC. 2. FINDINGS.

    Congress finds that:
            (1) An estimated 109,500 people in the United States will 
        be diagnosed with leukemia, lymphoma, and multiple myeloma in 
        2001.
            (2) New cases of the blood cancers described in paragraph 
        (1) account for 8.6 percent of new cancer cases.
            (3) Those devastating blood cancers will cause the deaths 
        of an estimated 60,300 persons in the United States in 2001. 
        Every 9 minutes, a person in the United States dies from 
        leukemia, lymphoma, or multiple myeloma.
            (4) While less than 5 percent of Federal funds for cancer 
        research are spent on those blood cancers, those blood cancers 
        cause 11 percent of all cancer deaths in the United States.
            (5) Increased Federal support of research into leukemia, 
        lymphoma, and multiple myeloma has resulted and will continue 
        to result in significant advances in the treatment, and 
        ultimately the cure, of those blood cancers as well as other 
        cancers.

SEC. 3. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD 
              CANCER.

    Part C of title IV of the Public Health Service Act (42 U.S.C. 285 
et seq.) is amended by inserting after section 419C the following:

``SEC. 417D. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD 
              CANCER.

    ``(a) Joe Moakley Research Excellence Program.--
            ``(1) In general.--The Director of NIH shall expand, 
        intensify, and coordinate programs for the conduct and support 
        of research with respect to blood cancer, and particularly with 
        respect to leukemia, lymphoma, and multiple myeloma.
            ``(2) Administration.--The Director of NIH shall carry out 
        this subsection through the Director of the National Cancer 
        Institute and in collaboration with any other agencies that the 
        Director determines to be appropriate.
            ``(3) Authorization of appropriations.--For the purpose of 
        carrying out this subsection, there is authorized to be 
        appropriated such sums as may be necessary for fiscal year 2002 
        and each subsequent fiscal year. Such authorizations of 
        appropriations are in addition to other authorizations of 
        appropriations that are available for such purpose.
    ``(b) Geraldine Ferraro Cancer Education Program.--
            ``(1) In general.--The Secretary shall direct the 
        appropriate agency within the Department of Health and Human 
        Services, in collaboration with the Director of NIH, to 
        establish and carry out a program to provide information and 
        education for patients and the general public with respect to 
        blood cancer, and particularly with respect to the treatment of 
        leukemia, lymphoma, and multiple myeloma.
            ``(2) Administration.--The Agency determined by the 
        Secretary under paragraph (1) shall carry out this subsection 
        in collaboration with private health organizations that have 
        national education and patient assistance programs on blood-
        related cancers.
            ``(3) Authorization of appropriations.--For the purpose of 
        carrying out this subsection, there is authorized to be 
        appropriated such sums as may be necessary for fiscal year 2002 
        and each subsequent fiscal year. Such authorizations of 
        appropriations are in addition to other authorizations of 
        appropriations that are available for such purpose.''.

            Passed the Senate November 16, 2001.

            Attest:

                                                  JERI THOMSON,

                                                             Secretary.
```